NatureWise Biotech & Medicals Corporation (4732)
Market Closed
16 Oct, 05:30 AM
NT$
16. 85
0
0%
NT$
- Market Cap
18.05 P/E Ratio
82.4% Div Yield
4,080 Volume
0 Eps
NT$ 16.85
Previous Close Want to track 4732 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NatureWise Biotech & Medicals Corporation (4732) Statistics
Valuation metrics
Market Cap -
Enterprise value 735.31M
Trailing P/E (ttm) -6.23
Forward P/E -
PEG ratio 0.05
Price/Sales (ttm) 4.76
Price/Book (mrq) 1.49
Enterprise Value/Revenue 4.21
Enterprise Value/EBITDA -4.63
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 5.15K
Average volume (90 days) 12.18K
Price summary
52-Week low 15.25
52-Week high 24.6
Beta -
50-Day moving average 17.66
200-Day moving average 17.98
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 29 Sep 2026
Ex-Dividend Date 29 Sep 2026
Last split factor 1,060:1,000
Last split Date 13 Sep 2021
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.77%
Operating margin -0.97%
Operational effectiveness
Return on assets -0.21%
Return on equity -0.23%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.63
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.78
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.5
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 7.05%
Book value per share (mrq) 11.53
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
